Table 6.
Time | Gene | G-R | Group GB-R | G-3PR | GB-3PR | p (G-R vs. GB-3PR) | p (GB-R vs. GB-3PR) | p (G-3PR vs. GB-3PR) |
---|---|---|---|---|---|---|---|---|
Day 3 | CD31 | 1.0 ± 0.047 | 1.7 ± 0.172 | 1.6 ± 0.078 | 2.1 ± 0.182 | 0.001 | 0.060 | 0.016 |
VEGF | 1.0 ± 0.116 | 1.2 ± 0.147 | 1.2 ± 0.148 | 1.7 ± 0.088 | 0.003 | 0.024 | 0.015 | |
PDGF | 1.0 ± 0.008 | 1.1 ± 0.049 | 1.0 ± 0.164 | 1.2 ± 0.057 | 0.008 | 0.042 | 0.226 | |
HIF1α | 1.1 ± 0.159 | 1.2 ± 0.086 | 1.2 ± 0.114 | 1.8 ± 0.226 | 0.022 | 0.032 | 0.033 | |
Day 7 | CD31 | 1.4 ± 0.072 | 2.3 ± 0.156 | 1.8 ± 0.149 | 2.9 ± 0.393 | 0.005 | 0.099 | 0.019 |
VEGF | 1.1 ± 0.078 | 1.6 ± 0.122 | 1.5 ± 0.103 | 2.4 ± 0.115 | <0.001 | 0.003 | 0.001 | |
PDGF | 1.3 ± 0.116 | 1.9 ± 0.066 | 2.2 ± 0.204 | 2.7 ± 0.286 | 0.003 | 0.026 | 0.124 | |
HIF1α | 1.2 ± 0.088 | 2.4 ± 0.059 | 2.2 ± 0.123 | 3.7 ± 0.153 | <0.001 | <0.001 | <0.001 |